MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (getgoal-x) Diabetes Care, May 24, 2013 Clinical Article
2 A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes Diabetic Medicine, May 24, 2013 Clinical Article
3 No identifiable Hb1Ac or lifestyle change after a comprehensive diabetes programme including motivational interviewing: A cluster randomised trial Full Text Scandinavian Journal of Primary Health Care, May 24, 2013 Clinical Article
4 Smoking Behavior among US Adults with Diabetes or Impaired Fasting Glucose American Journal of Medicine, May 24, 2013 Evidence Based Medicine Clinical Article
5 Cystic fibrosis-related diabetes compared to type 1 and type 2 diabetes in adults Diabetes/Metabolism Research and Reviews, May 24, 2013 Review Article
6 Diabetes distress in Type 1 diabetes—a new measurement fit for purpose Diabetic Medicine, May 24, 2013 Clinical Article
7 Women's experiences of gestational diabetes self-management: A qualitative study Midwifery, May 24, 2013 Clinical Article
8 The Diabetes Attitudes, Wishes and Needs second study(DAWN2) cross-national benchmarking indicators for family members living with people with diabetes Diabetic Medicine, May 24, 2013 Clinical Article
9 Extended family history of autoimmune diseases and phenotype and genotype of children with newly diagnosed type 1 diabetes European Journal of Endocrinology, May 24, 2013 Clinical Article
10 The skin landscape in diabetes mellitus. Focus on dermocosmetic management Full Text Clinical, Cosmetic and Investigational Dermatology, May 24, 2013 Review Article
11 Inpatient management of diabetes and hyperglycemia Clinical Therapeutics, May 24, 2013 Review Article
12 Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin Clinical Therapeutics, May 24, 2013 Clinical Article
13 To treat or not to treat? cost-effectiveness of ACE inhibitors in non-diabetic advanced renal disease - A Dutch perspective Full Text Kidney and Blood Pressure Research, May 24, 2013 Review Article
14 The rule of halves does not apply in peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants Critical Pathways in Cardiology, May 24, 2013 Clinical Article
15 The association between self-rated health and impaired glucose tolerance in Swedish adults: A cross-sectional study Full Text Scandinavian Journal of Primary Health Care, May 24, 2013 Clinical Article
16 Bullosis diabeticorum The Lancet, May 24, 2013
17 Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study The Lancet, May 23, 2013 Evidence Based Medicine Clinical Article
18 Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials Pain Practice, May 23, 2013 Clinical Article
19 Effect of consumption of micronutrient enriched wheat steamed bread on postprandial plasma glucose in healthy and type 2 diabetic subjects Full Text Nutrition Journal, May 23, 2013 Clinical Article
20 Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes Diabetic Medicine, May 23, 2013 Review Article
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summaryIndexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close